Division Further development of protocols and monitoring of rational use of antibiotics

United Kingdom

The activities to be developed are the following:

use of antibiotics in ambulatory care and in hospitals: analysis and report, including assessment of the burden of costs of treatment of drug resistant cases, including interfaces between hospitals, Community care, animals, food. This should also cover health effects and cost-benefit analysis of reduction in use of antibiotics in treating human illness.

[Call for proposals for projects]

Notes on Division 3

Footnotes

f1: See http://ec.europa.eu/health/ph_projects/project_en.htm
f2: Council Decision 2002/834/EC of 30 September 2002 adopting a specific programme for research, technological development and demonstration: ‘Integrating and strengthening the European Research Area’ (2002 to 2006) (OJ L 294, 29.10.2002, p. 1). FP6 public health related projects under scientific support to policies — Cordis web page: http://www.cordis.lu/lifescihealth/ssp.htm

Notes on Division 3.2.2.1

Footnotes

f1

Council Recommendation 2002/77/EC of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (OJ L 34, 5.2.2002, p. 13).

The report from the Commission to the Council on the basis of Member States’ reports on the implementation of Recommendation 2002/77/EC on the prudent use of antimicrobial agents in human medicine (22 December 2005): http://ec.europa.eu/health/ph_threats/com/mic_res/com684_en.pdf